We developed an oral vaccine platform using B. longum as an antigen-delivering vehicle to the intestinal immune system and generated a Wilms’ tumor 1 (WT1) oral anticancer vaccine that expresses WT1 protein—a tumor-associated antigen (TAA) [5]. This evidence concerns the gene WT1 and neoplasm.